Loading clinical trials...
Loading clinical trials...
This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Adaptive Phage Therapeutics, Inc.
Collaborators
NCT07463963 · Bladder Cancer, Transurethral Resection of the Bladder, and more
NCT06991686 · All Conditions Causing Sepsis, Pneumonia - Bacterial, and more
NCT05667207 · Cystitis Acute, Antibiotic Resistant Infection, and more
Universal Axon Clinical Research
Doral, Florida
AdMed Research
Miami, Florida
AMPM Research Clinic
Miami Gardens, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions